Apostolia M. Tsimberidou
机构:The University of Texas MD Anderson Cancer Center · ORCID:0000-0003-2713-233X
发表论文 995 篇 · 总被引 24058 次 · h-index 76
代表论文
- Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline (2026 · JCO Oncology Practice · 被引 8)
- A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma (2026 · Liver Cancer · 被引 1)
- Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases (2026 · Clinical Cancer Research)
- Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors (2026 · Frontiers in Immunology)
- Phase 2 dose-expansion trial of OBI-3424, a DNA-alkylating prodrug, in patients with advanced solid tumors expressing AKR1C3 (2026 · The Oncologist)
- Dose-expansion study of OBI-999, a Globo H-targeting antibody-drug conjugate, in patients with advanced solid tumors (2026 · The Oncologist)